Important Note: The information provided on any Fast Facts document is intended for use as a general eligibility checklist only. FAST FACTS ARE NOT TO BE USED AS TREATMENT SCHEMA. Contact GRCOP at (616) 391-1230 for specific patient eligibility requirements and the formal treatment plan.

Recently Activated Protocols

Cancer Type:	Advanced Renal
Research Base:	Sarah Cannon
Protocol:	GU 56
	Fast Facts

GU56: A Phase II Trial of Pazopanib in Patients with Metastatic Renal Cell Carcinoma Previously Treated with Sunitinib or Bevacizumab

Physician Summary: ≥ age 18; Unresectable Locally Recurrent or Metastatic w/Failed Prior Chemo: Oral Pazopanib

GYN

Cancer Type:	Endometrial
Research Base:	GOG
Protocol:	0248
	Fast Facts

0248: A Randomized Phase II Trial of Temsirolimus or the Combination of Hormonal Therapy Plus Temsirolimus in Women With Advanced, Persistent, or Recurrent Endometrial Carcinoma

Physician Summary: Stage III or IV; Persistent or Recurrent Endometrial: Temsirolimus vs Megestrol Acetate/Tamoxifen + Temsirolimus

Lung

Cancer Type:	NSCLC
Research Base:	RTOG
Protocol:	0618
	Fast Facts

0618: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the
Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer

Physician Summary: (St. Mary’s Only) > age 18; Operable Stage I/II: Stereotactic Body Radiation

Miscellaneous

Cancer Type:	Cytogenetic Studies
Research Base:	CALGB
Protocol:	8461
	Fast Facts

8461: Cytogenetic Studies In Acute Leukemia

Physician Summary: Previously Untreated AML, ALL, MDS: Bone Marrow and Blood Samples (Ancillary CALGB 9665 Required)